基础医学与临床 ›› 2022, Vol. 42 ›› Issue (7): 1124-1128.doi: 10.16352/j.issn.1001-6325.2022.07.1124

• 短篇综述 • 上一篇    下一篇

慢性肾脏病血管钙化机制的研究进展

熊浩, 袁芳*   

  1. 中南大学湘雅二医院 肾内科, 湖南 长沙 410011
  • 收稿日期:2021-03-08 修回日期:2021-07-17 出版日期:2022-07-05 发布日期:2022-06-29
  • 通讯作者: * 1278018214@qq.com
  • 基金资助:
    国家自然科学基金(81770730)

Research progress on vascular calcification mechanism for chronic kidney disease

XIONG Hao, YUAN Fang*   

  1. Department of Nephrology,the Second Xiangya Hospital,Central South University,Changsha 410011,China
  • Received:2021-03-08 Revised:2021-07-17 Online:2022-07-05 Published:2022-06-29
  • Contact: * 1278018214@qq.com

摘要: 心血管事件是慢性肾脏病(CKD)及终末期肾病(ESRD)患者主要的死亡原因。研究认为血管钙化是导致心血管事件的独立危险因素。应除了传统心血管事件的预防,在CKD患者中,关注血管钙化发生机制、平衡促钙化因素与抑钙化因素,是慢性肾脏病矿物质-骨代谢异常(CKD-MBD)防治首要关注的问题。

关键词: 慢性肾脏病, 血管钙化, 钙磷代谢, FGF23/Klotho, 炎性损伤

Abstract: Cardiovascular events are the main cause of death in chronic kidney disease(CKD) and end stage renal disease(ESRD).Studies have shown that vascular calcification is an independent risk factor for cardiovascular events.In addition to the prevention of cardiovascular events,paying attention to the mechanism of vascular calcification, keeping balance of pro-calcification factors and anti-calcification factors should be the primary concerns in prevention and treatment of chronic kidney disease with CKD-mineral and bone disorder(CKD-MBD) in CKD patients.

Key words: chronic kidney disease, vascular calcification, calcium and phosphate metabolism, FGF23/Klotho, inflammatory injury

中图分类号: